Jpharma SRL
Jpharma reported total assets of 345,274 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Aug 2026).
The score of Jpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +262 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Jpharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 3,475 € | ||||
| Equity | 109,115 € | ||||
| Cash | 36,972 € | ||||
| EBITDA | 27,003 € | ||||
| Total assets | 345,274 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 26 Sep 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Jpharma's financial analysis
- Solvency31.6%sector median: 51.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Jpharma
Jpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0562.799.542
- VAT number
- BE0562799542
- Peppol
- Registered · 0208:0562799542 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Sep 2014
- Registered office
- 4537 Verlaine
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Other liberal professions and professional, scientific and technical activities n.e.c. (NACE 74999)
Jpharma (SRL) has been based in Verlaine since 2014, active in: other liberal professions and professional, scientific and technical activities n.e.c.. For 2025, it reports a net profit of 3,475 € and equity of 109,115 €; its revenue is not published. Its solvency stands at 31.6%, below the median of its sector (51.2%).
Companies similar to Jpharma
Companies in the same business, of comparable size and area, outside its group.
- Clartys All other professional, scientific and technical activities n.e.c. Liège · balance sheet 136,775 €
- JFDS Conseil All other professional, scientific and technical activities n.e.c. Huy · balance sheet 311,345 €
- MKI Consulting All other professional, scientific and technical activities n.e.c. Ferrières · balance sheet 508,862 €
- Vetmedico Business and other management consultancy activities Pajottegem · balance sheet €2.25m
- Hangar 20 All other professional, scientific and technical activities n.e.c. Gembloux · balance sheet 76,104 €
- Alimac Consulting All other professional, scientific and technical activities n.e.c. Soumagne · balance sheet 10,780 €
- JFL Services All other professional, scientific and technical activities n.e.c. Bassenge · balance sheet 36,033 €
- Ahres All other professional, scientific and technical activities n.e.c. Walhain · balance sheet 35,035 €
Frequently asked questions about Jpharma
What is the revenue of Jpharma?
Jpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Jpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0562799542 for Jpharma, if the company is VAT-registered. Its company number (CBE) is 0562.799.542.
Where is the registered office of Jpharma?
According to the CBE register, the registered office of Jpharma is in 4537 Verlaine.
What is the equity of Jpharma?
At the close of the 2025 financial year, the equity of Jpharma amounts to 109,115 €, a solvency of 31.6% of total assets.
Who manages Jpharma?
The register lists 2 active mandates at Jpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Jpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →